Hematopoietic stem cell (CD34+) uptake of superparamagnetic iron oxide is enhanced by but not dependent on a transfection agent.


BACKGROUND AIMS Tracking the fate of cells after infusion would be a valuable asset for many stem cell therapies, but very few (cell) labels are approved for human therapeutic use. Superparamagnetic iron oxide particles (SPIO) can be internalized into stem cells in vitro to allow real-time tracking with gradient echo magnetic resonance imaging, but SPIO are… (More)
DOI: 10.1016/j.jcyt.2012.10.016



Citations per Year

Citation Velocity: 17

Averaging 17 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.